FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
FDA approves new drug to manage menopausal hot flashes
Fezolinetant (Veozah) targets the neural activity behind moderate to severe vasomotor symptoms.
FDA OKs new drug for Fabry disease
“The totality of clinical data suggests that Elfabrio has the potential to be a long-lasting therapy.”
FDA approves first drug to treat Alzheimer’s agitation
“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease.”
Medical students gain momentum in effort to ban legacy admissions
Opponents of legacy admissions say it penalizes students from racial minorities and lower socioeconomic backgrounds, hampering a fair and...
New protocol could cut fasting period to detect insulinomas
“These data support a 48-hour fast. The literature supports that’s sufficient to detect 95% of insulinomas.”
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”
FDA expands use of dapagliflozin to broader range of HF
The sodium-glucose cotransporter 2 inhibitor was previously approved in the United States for adults with heart failure with reduced ejection...
Veterans Will Benefit if the VA Includes Telehealth in its Access Standards
VA choice not to include telehealth in wait time calculations could have far-reaching...
The federal government paid private doctors twice by mistake for veterans’ care
Duplicate Medicare payments have doubled from $22 million in 2019 when the Veterans Community Care Program was implemented to $45 million in 2021...